E
ZyVersa Therapeutics, Inc. ZVSA
$0.7899 -$0.0111-1.39%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income -2.40M -2.76M -2.83M -13.34M -2.90M
Total Depreciation and Amortization 1.70K 10.40K 2.60K -113.50K 118.70K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 160.70K 162.50K 310.60K 12.06M 149.30K
Change in Net Operating Assets 1.59M 676.70K -1.26M -1.40M 1.70M
Cash from Operations -644.40K -1.91M -3.78M -2.79M -936.40K
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 828.00K 0.00 2.67M 5.00M 3.07M
Repurchase of Common Stock -- -- -- 0.00 0.00
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- 0.00 -230.00K
Total Dividends Paid -- -- -- -- --
Other Financing Activities -180.10K -- -- -653.50K -549.90K
Cash from Financing 647.80K 0.00 2.67M 4.35M 2.29M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- 0.00
Net Change in Cash 3.40K -1.91M -1.10M 1.56M 1.35M
Weiss Ratings